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Abstract
An enantioselective method for the synthesis of 1,2-anti diols has been developed. A
cyclometallated chiral-at-Ru complex catalyzes the asymmetric ring opening/cross metathesis of
di–oxygenated cyclobutenes, resulting in functionally rich synthetic building blocks. Syntheses of
the insect pheromone (+)-endo brevicomin and monosaccharide ribose demonstrate the synthetic
utility of the 1,2-anti diol fragments generated in the title reaction.
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The formation of multiple stereocenters in a single catalytic transformation is a powerful
approach to the synthesis of stereochemically complex targets. While the development of
such a transformation must overcome the challenge of simultaneously controlling diastereo-
and enantioselectivity, the end result can reduce the step count of a synthesis and improve its
atom economy. One commonly encountered motif is the vicinal diol, which is pervasive
throughout natural products and ligands for asymmetric transformations. While the problem
of introducing vicinal diols in high enantiopurity has largely been solved by the Sharpless
asymmetric dihydroxylation (AD), the formation of 1,2-anti diols remains challenging due
to the low enantioselectivity observed in the AD of cis-1,2 disubstituted alkenes.[1]
Accordingly, a number of methods have been developed for the enantioselective formation
of 1,2-anti diols, including asymmetric epoxidation/hydrolysis,[2] glycolate aldol,[3] iterative
cross metathesis/allylic substitution,[4] nucleophilic addition to aldehydes,[5]
desymmetrizing monofunctionalization,[6] and allene hydroboration/aldehyde allylation.[7]
In contrast to many of these methods, an asymmetric ring opening/cross metathesis
(AROCM) approach (Scheme 1) would consolidate the transformation into a single step and
generate a differentiated 1,5-diene fragment in a convergent manner.
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Asymmetric olefin metathesis is a powerful C–C bond forming reaction and has enabled the
synthesis of stereochemically complex bioactive compounds.[8] Advances in stereoselective
olefin metathesis have resulted in the development of catalysts capable of forming products
with high diastereo-[9] and enantioselectivity.[10] Although the ROCM of cyclobutenes to
form racemic products has been demonstrated,[11] previous studies of their AROCM
reactions have afforded products with low enantioenrichment.[10i]
It was envisioned that the desymmetrization of suitably substituted meso cyclobutenes in
AROCM would afford the 1,2-anti diol motif in perfect anti diastereoselectivity and
potentially high enantioselectivity upon application of a newly developed cyclometalated
metathesis catalyst (1, Scheme 1).[12] The resultant 1,5-diene would be a versatile synthetic
intermediate due to the differential reactivity of the two alkenes, paving the way for further
chemoselective transformations. Herein, we report the successful application of 1 to afford
highly enantioenriched 1,2-anti diols and demonstrate the versatility of these products in the
synthesis of the insect pheromone (+)-endo brevicomin and a derivative of the
monosaccharide L-ribose. Pest control strategies utilizing insect pheromones have become a
promising alternative to the application of broad-spectrum insecticides, underscoring the
importance of rapid synthetic routes to (+)-endo brevicomin and related bioactive
compounds.[13][14]
Initial attempts to form 1,2-anti diols were carried out with complex 1, allyl acetate (3), and
cis-3,4-dibenzyloxycyclobutene (2, Table 1), which was synthesized by substitution of
commercially available cis-3,4-dichlorocyclobutene with sodium phenylmethanolate.[15]
Solvent had no effect on selectivity of the AROCM reaction except for slightly diminished
enantioselectivity in CH2Cl2 (entry 1, Table 1); yield was highest in THF (entry 4). The
effect of stoichiometry in AROCM has been explored for a number of catalysts.[10b; 10i; 16]
In the current study, an excess of terminal olefin was optimal (7 equiv, entry 4); as the
equivalents of terminal olefin were reduced, the yield of the reaction dropped, yet a modest
yield of 29% could be obtained with 1.2 equivalents of 3. No di-cross products were
observed. Reducing the concentration also resulted in lower yield, leading to the optimal
conditions of 7 equiv. of terminal olefin 3 in THF at a concentration of 0.5 M in 2 with 1
mol% 1 for 1.5 h. It is worth noting that although alternative solvents or stoichiometry
negatively impacted reaction efficiency, the diastereo- and enantioselectivity remained
consistently high, demonstrating the robustness of the reaction.
While the synthesis of a 1,2-anti alkoxy motif had been demonstrated, inclusion of
alternative protecting groups on the diol motif strengthens the synthetic protocol. These
modifications would allow a synthetic sequence to be designed taking into account the
feasibility of removing the protecting groups in the presence of other functionality.
Moreover, modulation of the size and electronics of the groups on the cyclobutene and
terminal olefin reactants would provide a better understanding of the factors contributing to
selectivity.
A complement of commonly used hydroxyl protecting groups were tolerated on the
cyclobutene and terminal olefin reactants,[17] but enantio- and diastereoselectivity were
affected by the choice of substituents (Tables 2 and 3). The increased bulkiness of the tert-
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butyldimethylsilyl ether resulted in improved Z selectivity and remarkable enantioselectivity
(88% Z, 99% ee, 7a, Table 2), while hydroxyls and benzoates on the cyclobutene reactant
led to Z products with 91% and 96% ee, respectively. The same enantioinduction was
observed in products 7a and 7b. Isopropoxy substituents on the cyclobutene resulted in
abrogation of catalyst activity presumably due to the formation of a stable chelating
complex.[18]
High enantioselectivities were obtained with a wide range of terminal olefins. Among the O-
protecting groups surveyed (Table 3, 7e–h), the tert-butyldimethylsilyl group resulted in
high enantioselectivity (89% ee, 7g), but the more electron-withdrawing benzoate ester was
optimal, resulting in the highest enantioselectivity (97% ee, 7f). Terminal olefins bearing
alkyl substitution resulted in higher diastereoselectivity and yield with similar levels of
enantioselectivity (7i, j). The chiral allylation reagent 7k was synthesized in 91% ee,
affording a functionally useful building block. Z and E isomers were isolable from each
other by flash or thin layer chromatography in all cases except 7i.
We next explored the synthetic utility of the 1,2-anti diol fragments produced in the
AROCM reaction. Cyclic ketals derived from the 1,2-anti diol motif feature prominently in
the structures of several natural products.[19] Accordingly, we targeted this structure in the
context of a synthesis of the insect pheromone (+)-endo brevicomin (11, Scheme 2).[20]
(+)-Endo-brevicomin is a male produced component of the attractive pheromone system of
Dendroctonus frontalis (southern pine beetle),[19a] a tree-killing insect found in southern
North America and Central America. It was envisioned that AROCM of 2 with 4-penten-2-
ol would set the relative and absolute stereochemistry in the synthesis of (+)-endo
brevicomin.
An expedient three-step synthesis of (+)-endo brevicomin was accomplished featuring the
AROCM of 2 with racemic 8 to afford 9 (91% Z) in 85% yield as an inconsequential
mixture of diastereomers (Scheme 2). [21] The mixture of epimeric alcohols was cleanly
oxidized to the desired ketone by Dess-Martin periodinane in 88% yield. Z-10 was obtained
in 95% ee, indicating high enantioselectivity in the AROCM reaction. Hydrogenation of
Z-10 in acidic methanol resulted in concomitant reduction of the alkenes, hydrogenolysis of
the benzyl groups and cyclization to form (+)-endo brevicomin in 67% yield in a one-pot
transformation.[22]
It was envisioned that the synthetic utility of the 1,5-dienes produced in the AROCM of
cyclobutenes could be further underscored by chemoselective functionalization of the two
alkenes. For example, the introduction of additional hydroxyl groups would enable the rapid
synthesis of monosaccharides. In this fashion, a succinct and highly enantioselective
synthesis of biologically relevant monosaccharides could function as a robust route to
starting materials for complex polysaccharides.
The synthesis of ribose derivative 13 was carried out to demonstrate the conversion of
AROCM products such as 7 into useful monosaccharides (Scheme 3). Dihydroxylation of
Z-7f catalyzed by OsO4 afforded a 66% yield of differentially protected pentanol 12 in 9:1
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dr.[23] Ozonolysis of the remaining double bond afforded the differentially protected L-
ribose lactol, which was isolated as methyl glycoside 13 in 47% yield over two steps.[24] It
is hypothesized that a broader collection of monosaccharides will be accessible from the
AROCM products by the modification of this synthetic sequence.
In conclusion, the highly enantioselective synthesis of 1,2-anti diols was accomplished by
the application of catalyst 1 to the AROCM of cis-dioxygenated cyclobutenes. The reaction
is robust, tolerating modifications in reaction conditions and substitution on the reactants.
Enantioenrichment of the major Z isomers was exceptionally high, ranging from 89–99% ee.
The rapid synthesis of insect pheromone (+)-endo brevicomin was accomplished, affording
the natural product in 95% ee. A 1,5-diene generated by the AROCM reaction was
chemoselectively functionalized to afford ribose derivative 13, demonstrating the utility of
the building blocks afforded by the title reaction.
Experimental Section
In a glovebox, cyclobutene 2 (26.6 mg, 0.1 mmol) and allyl benzoate (113 mg, 0.7 mmol, 7
equiv) were dissolved in 0.15 mL THF. To this solution was added 50 μL of a stock solution
(0.02 M in THF) of catalyst 1. The reaction vial was capped and stirred for 1.5 h and then
quenched with an excess of ethyl vinyl ether outside of the glove box. The reaction mixture
was concentrated and subjected to flash chromatography to afford the desired AROCM
product (7f, 25.9 mg, 61% isolated yield, 88:12 Z/E, 97% ee (Z product), 88% ee (E
product)).
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Scheme 1.
AROCM Reaction to Afford Highly Enantioenriched 1,2-anti diols
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Scheme 2.
Enantioselective Synthesis of (+)-endo Brevicomin. a) 1 (1 mol%), rac-8 (7 equiv), THF,
23°C, 85% yield, 91% Z, 1:1 dr. b) Dess-Martin periodinane (2 equiv), 0–23°C, 88% yield,
95% ee. c) H2 (1 atm), Pd/C (10%), MeOH/aq. 1N HCl, 67% yield.
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Scheme 3.
Enantioselective Synthesis of an L-Ribose Derivative. a) OsO4 (5 mol%), K3Fe(CN)6,
K2CO3, tBuOH/water, 66% yield, 9:1 dr. b) O3 then Me2S. c) HCl in MeOH (anh.), 47%
yield (over two steps).
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